The Role of Fecal Microbiota Transplantation in Reducing Intestinal Colonization With Antibiotic-Resistant Organisms: The Current Landscape and Future Directions
- PMID: 31363779
- PMCID: PMC6667716
- DOI: 10.1093/ofid/ofz288
The Role of Fecal Microbiota Transplantation in Reducing Intestinal Colonization With Antibiotic-Resistant Organisms: The Current Landscape and Future Directions
Erratum in
-
Corrigendum: The Role of Fecal Microbiota Transplantation in Reducing Intestinal Colonization With Antibiotic-Resistant Organisms: The Current Landscape and Future Directions.Open Forum Infect Dis. 2019 Oct 20;6(10):ofz391. doi: 10.1093/ofid/ofz391. eCollection 2019 Oct. Open Forum Infect Dis. 2019. PMID: 31660354 Free PMC article.
Abstract
The intestinal tract is a recognized reservoir of antibiotic-resistant organisms (ARO), and a potential target for strategies to reduce ARO colonization. Microbiome therapies such as fecal microbiota transplantation (FMT) have been established as an effective treatment for recurrent Clostridioides difficile infection and may be an effective approach for reducing intestinal ARO colonization. In this article, we review the current published literature on the role of FMT for eradication of intestinal ARO colonization, review the potential benefit and limitations of the use of FMT in this setting, and outline a research agenda for the future study of FMT for intestinal ARO colonization.
Keywords: antibiotic resistance; antibiotic-resistant organism; fecal microbiota transplantation; hospital epidemiology; microbiome; multidrug-resistant organisms; resistome.
© The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Figures

Similar articles
-
The role of the gut microbiome in colonization resistance and recurrent Clostridioides difficile infection.Therap Adv Gastroenterol. 2022 Nov 18;15:17562848221134396. doi: 10.1177/17562848221134396. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 36425405 Free PMC article. Review.
-
Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.mSphere. 2020 Oct 14;5(5):e00853-20. doi: 10.1128/mSphere.00853-20. mSphere. 2020. PMID: 33055258 Free PMC article.
-
The role of microbiome-based therapeutics for the reduction and prevention of antimicrobial-resistant organism colonization.Anaerobe. 2023 Oct;83:102772. doi: 10.1016/j.anaerobe.2023.102772. Epub 2023 Aug 10. Anaerobe. 2023. PMID: 37572864 Review.
-
A microbial consortium alters intestinal Pseudomonadota and antimicrobial resistance genes in individuals with recurrent Clostridioides difficile infection.mBio. 2023 Aug 31;14(4):e0348222. doi: 10.1128/mbio.03482-22. Epub 2023 Jul 5. mBio. 2023. PMID: 37404011 Free PMC article.
-
Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study.Genome Med. 2021 Feb 16;13(1):28. doi: 10.1186/s13073-021-00843-9. Genome Med. 2021. PMID: 33593430 Free PMC article. Clinical Trial.
Cited by
-
Gut microbiota, circulating inflammatory proteins and sepsis: a bi-directional Mendelian randomization study.Front Cell Infect Microbiol. 2024 Aug 8;14:1398756. doi: 10.3389/fcimb.2024.1398756. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39176264 Free PMC article.
-
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.Clin Infect Dis. 2023 Oct 16;77(Suppl 4):S295-S304. doi: 10.1093/cid/ciad565. Clin Infect Dis. 2023. PMID: 37843115 Free PMC article. Review.
-
Fecal Microbial Transplantation for the Treatment of Persistent Multidrug-Resistant Klebsiella pneumoniae Infection in a Critically Ill Patient.Case Rep Infect Dis. 2020 Feb 12;2020:8462659. doi: 10.1155/2020/8462659. eCollection 2020. Case Rep Infect Dis. 2020. PMID: 32099702 Free PMC article.
-
Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides difficile Infection.bioRxiv [Preprint]. 2024 May 2:2024.04.30.591969. doi: 10.1101/2024.04.30.591969. bioRxiv. 2024. Update in: J Infect Dis. 2025 Jul 11;231(6):1392-1406. doi: 10.1093/infdis/jiae470. PMID: 38746249 Free PMC article. Updated. Preprint.
-
Faecal microbiota transplantation for multidrug-resistant organism decolonization in spinal cord injury patients: a case series.Infect Prev Pract. 2024 Jan 27;6(1):100340. doi: 10.1016/j.infpip.2024.100340. eCollection 2024 Mar. Infect Prev Pract. 2024. PMID: 38357521 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Antibiotic/antimicrobial resistance (AR/AMR): biggest threats and data. Available at: https://www.cdc.gov/drugresistance/threat-report-2013/index.html. Accessed 23 February 2018.
-
- Elemam A, Rahimian J, Mandell W. Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature. Clin Infect Dis 2009; 49:271–4. - PubMed
-
- Donskey CJ. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis 2004; 39:219–26. - PubMed